Beth Warren, MD
Assistant Professor, Pediatrics

Photo
Medical School:
  • MD, University of Texas Southwestern Medical Center at Dallas Southwestern Medical School (2009)
Graduate Schools :
  • MS, Emory University (2005)
  • MSc, University of Colorado Health Sciences Center (2019)
Undergraduate School:
  • BS, Rice University (TX) (2002)
Residency:
  • University of Colorado (Children's Hospital Colorado) Program, Pediatrics (2012)
Fellowships:
  • University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology (2015)
  • University of Colorado (Children's Hospital Colorado) Program, Pediatric Hemostasis and Thrombosis
Languages: English
Department: Pediatrics

Professional Titles

  • Assistant Professor, Department of Pediatrics

Research Interests

My primary research interest is hemophilia. My research goal is to eliminate breakthrough bleeding by better understanding the biomechanics of joint and muscle bleeding, and by better understanding what factor levels are needed to prevent breakthrough bleeding in specific situations.

Publications

  • Warren BB, Chan A, Manco-Johnson M, Branchford BR, Buckner TW, Moyer G, Gibson E, Thornhill D, Wang M, Ng CJ. Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single-center report. Res Pract Thromb Haemost. 2021 Jul;5(5):e12571. PubMed PMID: 34377887
  • Smith N, Warren BB, Smith J, Jacobson L, Armstrong J, Kim J, Di Paola J, Manco-Johnson M. Antithrombin deficiency: A pediatric disorder. Thromb Res. 2021 Jun;202:45-51. PubMed PMID: 33725558
  • Smith J, Thornhill D, Goldenberg NA, Brandão L, Knapp-Clevenger R, Warren BB, Sung L, Kahn SR, Manco-Johnson M. Validation of Outcome Instruments for Pediatric Postthrombotic Syndrome: Introducing the Peds-VEINES-QOL, a New Health-Related Quality of Life Instrument. Thromb Haemost. 2021 Oct;121(10):1367-1375. PubMed PMID: 33706398
  • Manco-Johnson MJ, Warren BB, Buckner TW, Funk SM, Wang M. Outcome measures in Haemophilia: Beyond ABR (Annualized Bleeding Rate). Haemophilia. 2021 Feb;27 Suppl 3:87-95. PubMed PMID: 33398908
  • Maher KN, Gibson E, Warren BB, Funk SM, Shearer R, Buckner TW, Wang M, Manco-Johnson MJ, Ng CJ. Prophylaxis for children with moderate hemophilia: Use of a guideline to increase early initiation. Pediatr Blood Cancer. 2021 Jan;68(1):e28577. PubMed PMID: 32881253
  • Ng CJ, Spomer N, Shearer R, LeBlanc A, Funk S, Manco-Johnson M, Branchford B, Warren B, Buckner TW, Cowell A, Moyer G, Wang M, Gibson E, Mashburn C. Improvements in Communication and Coordination of Care in a Hemophilia Treatment Center. Acta Haematol. 2021 Apr 29;:1-6. [Epub ahead of print] PubMed PMID: 33915533
  • Warren BB, Thornhill D, Stein J, Fadell M, Ingram JD, Funk S, Norton KL, Lane HD, Bennett CM, Dunn A, Recht M, Shapiro A, Manco-Johnson MJ. Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study. Blood Adv. 2020 Jun 9;4(11):2451-2459. PubMed PMID: 32492157
  • Slatnick LR, Thornhill D, Deakyne Davies SJ, Ford JB, Scott HF, Manco-Johnson MJ, Warren BB. Disseminated Intravascular Coagulation Is an Independent Predictor of Adverse Outcomes in Children in the Emergency Department with Suspected Sepsis. J Pediatr. 2020 Oct;225:198-206.e2. PubMed PMID: 32553867
  • Maher KN, Gibson E, Warren BB, Funk SM, Shearer R, Buckner TW, Wang M, Manco-Johnson MJ, Ng CJ. Prophylaxis for children with moderate hemophilia: Use of a guideline to increase early initiation. Pediatr Blood Cancer. 2020 Sep 2;:e28577. [Epub ahead of print] PubMed PMID: 32881253
  • Slatnick LR, Thornhill D, Deakyne Davies SJ, Ford JB, Scott HF, Manco-Johnson MJ, Warren BB. Disseminated Intravascular Coagulation Is an Independent Predictor of Adverse Outcomes in Children in the Emergency Department with Suspected Sepsis. J Pediatr. 2020 Oct;225:198-206.e2. PubMed PMID: 32553867
  • Warren BB, Jacobson L, Kempton C, Buchanan GR, Recht M, Brown D, Leissinger C, Shapiro AD, Abshire TC, Manco-Johnson MJ. Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes. Haemophilia. 2019 Sep;25(5):867-875. PubMed PMID: 31115111
View All (11 Total) View Less

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Hemophilia & Thrombosis Center
13199 E. Montview Blvd
Suite 100
Aurora, CO 80045
303-724-0724

Hospital Affiliation
  • Children's Hospital Colorado
Center Affiliations

Specialty Information

Specialties
  • Pediatric Hematology / Oncology, Board Certification
  • Pediatrics, Board Certification
Conditions & Treatments
  • Cancers - Blood and Marrow Transplant
  • Cancers
  • Blood / Lymphatic System - Bleeding Disorders
  • Blood / Lymphatic System
  • Blood / Lymphatic System - Clotting Disorders
Clinical Interests
Hemophilia, bleeding disorders, clotting disorders, clots in congenital heart disease, heavy menstrual bleeding

Care Philosophy
My goal is to help patients manage their bleeding or clotting problems in an integrative way that focuses on enjoying life and minimizing long-term effects.

Personal Interests
My personal research interest is to better prevent bleeding in patients with hemophilia. I think that bleeding happens in joints and muscles when the amount of factor medication in the body is too low to prevent bleeding when joints and muscles are stressed by physical activities. I am collaborating with our orthopedics department to better understand the physical stresses on joints and muscles during activities, so that we can better tailor factor medication dosing to prevent bleeding.

General Information

Medical Schools:
  • MD, University of Texas Southwestern Medical Center at Dallas Southwestern Medical School (2009)
Graduate Schools:
  • MS, Emory University (2005)
  • MSc, University of Colorado Health Sciences Center (2019)
Undergraduate Schools:
  • BS, Rice University (TX) (2002)
Residency Programs:
  • University of Colorado (Children's Hospital Colorado) Program, Pediatrics (2012)
Fellowships:
  • University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology (2015)
  • University of Colorado (Children's Hospital Colorado) Program, Pediatric Hemostasis and Thrombosis (0001)
Languages: English
Department: Pediatrics
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;